No Interaction Expected
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP)
Quality of Evidence:
Coadministration has not been studied. Clofibrate is metabolised mainly to an active metabolite, clofibric acid. Excretion of clofibric acid glucuronide is possibly performed via OAT1. OAT1 does not participate in emtricitabine renal excretion. No clinically significant increases in clofibrate or tenofovir are anticipated as a result of competition for renal secretion via OAT1.
View all available interactions with
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP) by clicking